Among the individuals with an SCN5A mutation, 27 percent had early features of DCM, 38 percent had full-blown DCM and 43 percent had atrial fibrillation, a rhythm abnormality in the upper chambers of the heart.
"Ironically, the fact that this gene encoding the sodium channel has been strongly implicated in heart rhythm disturbances may have hindered identification of its role in heart failure," says Timothy Olson, M.D. the Mayo Clinic pediatric cardiologist who led the study. "In previous studies of patients and families searching for mutations in this gene, those with structural heart disease such as DCM were normally excluded from consideration in order to better focus on the rhythm disorders. With this new study, we see that heart failure is another important manifestation of this genetic defect."
A Mayo Clinic study led by co-author Virginia Michels, M.D., and published in New England Journal of Medicine in 1992, established the importance of genetics in DCM. Until now, the mutations shown to cause DCM have mainly been related to the proteins involved in the heart's structure and contraction. The new study is important because it establishes another mechanism for heart failure involving the regulation of sodium ion flow, not structural protein defects.
"Our findings may broaden the indications for genetic screening of SCN5A beyond isolated rhythm disorders," says Dr. Olson. "Since these variations hinder sodium transport, it may be wise to avoid using
'"/>
Contact: Lee Aase
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
25-Jan-2005